Health Disparities in Cancer Care
Minorities in the US bear a disproportionate burden of cancer compared with other population groups. The health disparities and measurable differences in outcomes manifest across the cancer care continuum, from prevention and diagnosis, through treatment, monitoring and mortality.
This understanding guided ConcertAI to form ERACE (Engaging Research to Achieve Cancer Care Equity), a multidisciplinary initiative to better understand cancer disparities and create innovative solutions to eliminate them.
Otis W. Brawley, MD
Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from 2007 to 2018.
Tuya Pal, MD
Tuya Pal is Associate Director of Cancer Health Disparities and Ingram Professor of Cancer Research at the Vanderbilt-Ingram Cancer Center, a practicing Clinical Geneticist focused on Inherited Cancers, and Professor of Medicine at the Vanderbilt University Medical Center.
Christopher Lathan, MD, MS, MPH
Chris Lathan is a Medical Director at the Dana-Farber Cancer Institute, a Faculty Director at the Cancer Care Equity Program, Pulmonary Oncologist and Assistant Professor of Medicine at Harvard Medical School.
Erica Warner, ScD, MPH
Dr. Warner is an Assistant Professor in the Department of Medicine at Harvard Medical School and an Assistant Investigator at MGH. She is a member of the Dana-Farber Harvard Cancer Center in the Cancer Epidemiology and Risk and Health Disparities Programs.